304am永利集团|·主頁(歡迎您)

Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX02
Healthy Male Subjects
Phase I

A Study of Safety and Tolerability of HLX02 with Different Dose and a Phase I Study Comparing HLX02 and Herceptin®(U.S. and German)

HLX02
BC
Phase III

A Phase III Study Comparing the Safety and Efficacy of HLX02 and Herceptin®(U.S. and German) in Breast Cancer

HLX01
CD20-Positive B-cell Lymphomas
Phase Ia

A Phase Ia Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients with CD20-positive B-cell Lymphomas

HLX01
CD20-positive B-cell Lymphomas
Phase I

A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 and Rituximab

HLX01
DLBCL
Phase III

Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

Baidu
sogou